BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 30779084)

  • 1. Effect of miR-34a on resistance to sunitinib in breast cancer by regulating the Wnt/β-catenin signaling pathway.
    Gong LG; Shi JC; Shang J; Hao JG; Du X
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1151-1157. PubMed ID: 30779084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-34a Inhibits Breast Cancer Proliferation and Progression by Targeting Wnt1 in Wnt/β-Catenin Signaling Pathway.
    Si W; Li Y; Shao H; Hu R; Wang W; Zhang K; Yang Q
    Am J Med Sci; 2016 Aug; 352(2):191-9. PubMed ID: 27524218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo and in vitro effects of microRNA-27a on proliferation, migration and invasion of breast cancer cells through targeting of SFRP1 gene via Wnt/β-catenin signaling pathway.
    Kong LY; Xue M; Zhang QC; Su CF
    Oncotarget; 2017 Feb; 8(9):15507-15519. PubMed ID: 28099945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knockdown of long non-coding RNA HOTAIR inhibits cisplatin resistance of gastric cancer cells through inhibiting the PI3K/Akt and Wnt/β-catenin signaling pathways by up-regulating miR-34a.
    Cheng C; Qin Y; Zhi Q; Wang J; Qin C
    Int J Biol Macromol; 2018 Feb; 107(Pt B):2620-2629. PubMed ID: 29080815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-34a modulates chemosensitivity of breast cancer cells to adriamycin by targeting Notch1.
    Li XJ; Ji MH; Zhong SL; Zha QB; Xu JJ; Zhao JH; Tang JH
    Arch Med Res; 2012 Oct; 43(7):514-21. PubMed ID: 23085450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [miR-34a may regulate sensitivity of breast cancer cells to adriamycin via targeting Notch1].
    Li X; Zhao J; Tang J
    Zhonghua Zhong Liu Za Zhi; 2014 Dec; 36(12):892-6. PubMed ID: 25623761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-122 enhances sensitivity of hepatocellular carcinoma to oxaliplatin via inhibiting MDR1 by targeting Wnt/β-catenin pathway.
    Cao F; Yin LX
    Exp Mol Pathol; 2019 Feb; 106():34-43. PubMed ID: 30539797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Long Noncoding RNA NEAT1 Targets miR-34a-5p and Drives Nasopharyngeal Carcinoma Progression via Wnt/β-Catenin Signaling.
    Ji Y; Wang M; Li X; Cui F
    Yonsei Med J; 2019 Apr; 60(4):336-345. PubMed ID: 30900419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-34a Inhibitor May Effectively Protect against Sevoflurane-Induced Hippocampal Apoptosis through the Wnt/β-Catenin Pathway by Targeting Wnt1.
    Zhao X; Sun Y; Ding Y; Zhang J; Li K
    Yonsei Med J; 2018 Dec; 59(10):1205-1213. PubMed ID: 30450855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-100 suppresses the migration and invasion of breast cancer cells by targeting FZD-8 and inhibiting Wnt/β-catenin signaling pathway.
    Jiang Q; He M; Guan S; Ma M; Wu H; Yu Z; Jiang L; Wang Y; Zong X; Jin F; Wei M
    Tumour Biol; 2016 Apr; 37(4):5001-11. PubMed ID: 26537584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-34a regulates cell apoptosis after myocardial infarction in rats through the Wnt/β-catenin signaling pathway.
    Li JH; Dai J; Han B; Wu GH; Wang CH
    Eur Rev Med Pharmacol Sci; 2019 Mar; 23(6):2555-2562. PubMed ID: 30964183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-340 inhibits the migration, invasion, and metastasis of breast cancer cells by targeting Wnt pathway.
    Mohammadi-Yeganeh S; Paryan M; Arefian E; Vasei M; Ghanbarian H; Mahdian R; Karimipoor M; Soleimani M
    Tumour Biol; 2016 Jul; 37(7):8993-9000. PubMed ID: 26758430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel miR-34a target, protein kinase D1, stimulates cancer stemness and drug resistance through GSK3/β-catenin signaling in breast cancer.
    Kim do Y; Park EY; Chang E; Kang HG; Koo Y; Lee EJ; Ko JY; Kong HK; Chun KH; Park JH
    Oncotarget; 2016 Mar; 7(12):14791-802. PubMed ID: 26895471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delphinidin suppresses breast carcinogenesis through the HOTAIR/microRNA-34a axis.
    Han B; Peng X; Cheng D; Zhu Y; Du J; Li J; Yu X
    Cancer Sci; 2019 Oct; 110(10):3089-3097. PubMed ID: 31325197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-494 suppresses the progression of breast cancer in vitro by targeting CXCR4 through the Wnt/β-catenin signaling pathway.
    Song L; Liu D; Wang B; He J; Zhang S; Dai Z; Ma X; Wang X
    Oncol Rep; 2015 Jul; 34(1):525-31. PubMed ID: 25955111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-148a inhibits breast cancer migration and invasion by directly targeting WNT-1.
    Jiang Q; He M; Ma MT; Wu HZ; Yu ZJ; Guan S; Jiang LY; Wang Y; Zheng DD; Jin F; Wei MJ
    Oncol Rep; 2016 Mar; 35(3):1425-32. PubMed ID: 26707142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progesterone ameliorates the endometrial polyp by modulating the signaling pathway of Wnt and β-catenin via regulating the expression of H19 and miR-152.
    Feng M; Zhang T; Ma H
    J Cell Biochem; 2019 Jun; 120(6):10164-10174. PubMed ID: 30659641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of miR-7 on resistance of breast cancer cells to adriamycin via regulating EGFR/PI3K signaling pathway.
    Huang Q; Wu YY; Xing SJ; Yu ZW
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5285-5292. PubMed ID: 31298380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulated GBX2 gene suppresses proliferation, invasion and angiogenesis of breast cancer cells through inhibiting the Wnt/β-catenin signaling pathway.
    Fang Y; Yuan Y; Zhang LL; Lu JW; Feng JF; Hu SN
    Cancer Biomark; 2018; 23(3):405-418. PubMed ID: 30223390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long non-coding RNA XIST sponges miR-34a to promotes colon cancer progression via Wnt/β-catenin signaling pathway.
    Sun N; Zhang G; Liu Y
    Gene; 2018 Jul; 665():141-148. PubMed ID: 29679755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.